Leerink Partners
Tracked across 11 events · 93 articles · First seen Feb 04, 2026 · Last active Apr 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Leerink Partners LLC became the exclusive sales agent for OKYO Pharma's ATM facility, replacing B. Riley Financial===B. Riley Securities Inc. This partnership is expected to leverage Leerink Partners' expertise in the biotech sector and investor relationships, earning them a 3.0% commission on gross proceeds from shares sold.
Feb 11, 2026 · 8 articles
Business
Leerink Partners is acting as a joint book-running manager for the Kalera Therapeutics IPO, playing a key role in the offering's execution and gaining visibility in the biotechnology investment sector.
Apr 16, 2026 · 8 articles
Business
Leerink Partners is acting as a joint book-running manager for Trevi Therapeutics' public offering, assisting in the sale of shares.
Apr 16, 2026 · 11 articles
Business
Leerink Partners acted as a joint book-running manager for Satellos Bioscience Inc.'s public offering, facilitating the successful completion of the transaction.
Feb 05, 2026 · 10 articles
Business
Leerink Partners LLC is acting as a book-running manager for the public offering of Vir Biotechnology, assisting in the sale of shares.
Feb 24, 2026 · 10 articles
+ 6 more events
View on Dashboard
70
Leerink Partners acted as joint book-running manager Kalera TherapeuticsKalera Therapeutics Prices...
70
Leerink Partners acted as joint book-running manager Trevi TherapeuticsTrevi Therapeutics Prices...
NEWSDESK
Track Leerink Partners live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard